Specific immunotherapy in the treatment of patients with atopic dermatitis - Results of double blind placebo controlled study;Immunoterapia swoista w leczeniu chorych na atopowe zapalenie skóry - Wyniki badania prowadzonego w warunkach podwójnie ślepej próby

Polski Merkuriusz Lekarski

Volumn 21, Issue 126, 2006, Pages 558-565

  Silny, Wojciech ^a,b,c   Czarnecka Operacz, Magdalena ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Akademia Medyczna W Poznaniu   (Poland)

^c Katedra i Klinika Dermatologii   (Poland)

Author keywords

Atopic dermatitis; Specific immunotherapy

Indexed keywords

ALLERGEN; ALUMINUM HYDROXIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INSECT VENOM; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; VACCINATION;

ADOLESCENT; ADULT; ALLERGENS; ANALYSIS OF VARIANCE; ANTIGENS, DERMATOPHAGOIDES; CHILD; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; MALE; POLLEN; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33846391694     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Akdis C.A., M. Akdis, D. Simon et al.: T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol., 1999, 113, 628-634.
2. Akdis M., C.A. Akdis, L. Weigl, R. Disch, K. Blaser: Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an II-13-dominated cytokine pattern. IgG4 counter-regulation by CLA-memory T cells. J. Immunol., 1997, 159, 4611-4619 .
3. Akdis M., H.U. Simon, L. Weigl, O. Kreyden, K. Blaser, C.A. Akdis: Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J .Immunol., 1999, 163, 466-475.
4. Akdis M. A., Trautmann, S. Klunker, K. Blaser, C.A. Akdis: T cells and effector functions in atopic dermatitis. ACI International, 2002, 14, 161-164.
5. Akdis M., J. Verhagen , A. Taylor et al.: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergenspecific T regulatory 1 and T helper 2 cells. J. Exp. Med., 2004, 199, 1567-1575.
6. Antúnez C., M.J. Torres, C. Mayorga et al.: Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte- associated antigen+ T cells from patients with acute or chronic atopic dermatitis. Clin. Exp. Allergy, 2004, 34, 559-566.
7. Blaser K., C.A. Akdis: Interleukin-10, T regulatory cells and specific allergy treatment. Clin. Exp. Allergy, 2004, 34, 328-331.
8. Breuer K., A. Kapp, T. Werfel: Bacterial infections and atopic dermatitis. Allergy, 2001, 56, 1034-1041.
9. Chait J., V. Allkins: Remission of life-long atopic dermatitis after hyposensitization to house dust mite. Practitioner, 1985, 229, 609-612.
10. Czarnecka-Operacz M., M. Bator-Wegner, W. Silny: Atopy patch test reaction to airborne allergens In the diagnosis of atopic dermatitis. Acta Dermatovenereol. Croat., 2005, 13, 3-16.
11. Czarnecka-Operacz M., W. Silny: Specific immunotherapy in atopic dermatitis: 48 months of treatment in different age-related groups. (Submitted to Acta Dermatovenerol. Croat.).
12. Czech W., J. Krutmann, E. Schöpfe, A. Kapp: Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br. J. Dermatol., 1992, 126, 351-355.
13. Di Prisco de Fuenmayor M.C., R.H. Champion: Specific hyposensitization in atopic dermatitis. Br. J. Dermatol., 1979, 101, 697-707.
14. Glover M.T., D.J. Atherton: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin. Exp. Allergy, 1992, 22, 440-446.
15. Grewe M., C.A.F.M. Bruijnzeel-Koomen, T. Thepen et al.: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunology Today, 1998, 19, 359-361.
16. Kapp A.: The role of eosinophils in the pathogenesis of atopic dermatitis - eosinophil granule proteins as markers of disease activity. Allergy, 1993, 48, 1-5.
17. Kapp A., R. Gillizer, H. Kichner et al.: Production of interferon and lymphoproliferative responses in whole blood cultures derived from patients with atopic dermatitis. Arch. Dermatol. Res., 1987, 279, 55-58.
18. Kapp A., P. Neuner, J. Krutmann et al.: Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels. Acta Derm. Venereol., 1991, 71, 403-406.
19. Kapp A., A. Piskorski, E. Schöpf: Elevated levels of interleukin-2 receptor in sera of patients with atopic dermatitis and psoriasis. Br. J. Dermatol., 1988, 119, 707-710.
20. Kaufman H.S., H.L. Roth: Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo controlled study. Annals Allergy, 1974, 32, 321-330.
21. Michils A., C.M. Farber, J.P. Van Vooren et al.: Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis. Br. J. Dermatol., 1994, 130, 134-135.
22. Nouri-Aria K.T., P.A. Wachholz, J.N. Francis: Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J. Immunol., 2004, 172, 3252-3259.
23. Novak N., T. Bieber, D.Y.M. Leung: Immune mechanisms leading to atopic dermatitis. J. Allergy Clin. Immunol., 2003, 112, S128-139.
24. Ohshima Y., K. Katamura, M. Miura et al.: Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders. Eur. J. Pediatr., 1995, 154, 723-728 .
25. O'Loughlin S, J.L.Diaz-Perez, G.J. Gleich et al.: Serum IgE in dermatitis and dermatosis. Arch. Dermatol., 1997, 113, 309-312.
26. Pacor M.L., D. Biasi, T. Malekina: The efficacy of long-term specificimmunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis. Recenti. Prog. Med., 1994, 85, 273-277.
27. Ring J.: Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br. J. Dermatol., 1982, 93, 597-602 .
28. Robinson D.S., M. Larche, S.R. Durham: Tregs and allergic disease. J. Clin. Invest.,2004, 114, 1389-1397.
29. Silny W., M. Czarnecka-Operacz, P. Silny: The new scoring system for evaluation of skin inflammation Entent and severity in patients with atopic dermatitis. Acta Dermatovenerol. Croat., 2005, 13, 219-224.
30. Silny W., M. Czarnecka-Operacz , P. Silny: Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part 1. Evaluation of clinical score. Wiad. Lek., 2005, 57,47-55.
31. Silny W., M. Czarnecka-Operacz, P. Silny.: Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part 2. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens. Wiad. Lek., 2005, 58, 184-191.
32. Silny W., M. Czarnecka-Operacz, P. Silny: Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part 3. Serum concentrations of selected immunological parameters. Wiad. Lek., 2005, 58, 287-294.
33. Stuart J.H.: Specific hyposensitization for atopic dermatitis: a new era? Dermatologica,1991, 182, 71-72.
34. Thestrup-Pedersen K., C. Schade Larsen, M. Kristensen, et al.: Interleukin- 1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis. Acta Derm. Venereol., 1990, 70, 395-399.
35. Werfel T., A. Kapp: Environmental and other provocation factors in atopic dermatitis. Allergy, 1998, 53, 731-739.
36. Werfel T., K. Breuer, F. Rueff, B. Przybilla et al.: Usefulness of specific immunotherapy in patients with atopic dermatitis and alleregic sensitization to house dust mites: a multicenter, randomized, dose-response study. Allergy, 2006, 61, 202-205.
37. Wittig H.I., I. Belloit, I. de Fillippi et al.: Age related serum immunoglobulin E levels in healthy subjects and patients with allergic diseases. J. Allergy Clin. Immunol., 1980, 66, 305-307.
38. Zachariae H., M. Cramers, T. Herlin, et al.: Non-specific and specific hyposensitization in severe atopic dermatitis. Acta Derm. Venerol.,1985, 114, 48-54.